Patient characteristics		E2, 1 mg (%)	E2, 1 mg + NETA, 0.1 mg (%)	E2, 1 mg + NETA, 0.25 mg (%)	E2, 1 mg + NETA, 0.5 mg (%)
Number of patients randomized		296	294	291	295
Number of available biopsies		247	249	251	241
Number normal		189 (76.5)	246 (98.8)	250 (99.6)	240 (99.6)
Number with disordered proliferative phase		21 (8.5)	1 (0.4)	0 (0.0)	0 (0.0)
Number with endometrial hyperplasia		36 (14.6)	2 (0.8)	1 (0.4)	1 (0.4)
	Simple without atypia	30 (12.2)	1 (0.4)	0 (0.0)	1 (0.4)
	Complex without atypia	4 (1.6)	0 (0.0)	0 (0.0)	0 (0.0)
	Simple with atypia	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
	Complex with atypia	2 (0.8)	1 (0.4)	1 (0.4)	0 (0.0)
Number with carcinoma		0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
Number with other conditions		1 (0.4)*	0 (0.0)	0 (0.0)	0 (0.0)